196 related articles for article (PubMed ID: 16061810)
21. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract.
Collins KB; Patterson BK; Naus GJ; Landers DV; Gupta P
Nat Med; 2000 Apr; 6(4):475-9. PubMed ID: 10742159
[No Abstract] [Full Text] [Related]
22. Genital HIV shedding in women.
Iversen AK
AIDS Patient Care STDS; 1999 Dec; 13(12):695-701. PubMed ID: 10743532
[TBL] [Abstract][Full Text] [Related]
23. Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and -seronegative women.
Calabrò ML; Fiore JR; Favero A; Lepera A; Saracino A; Angarano G; Schulz TF; Chieco-Bianchi L
J Infect Dis; 1999 Jun; 179(6):1534-7. PubMed ID: 10228077
[TBL] [Abstract][Full Text] [Related]
24. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins.
Fichorova RN; Rheinwald JG; Anderson DJ
Biol Reprod; 1997 Oct; 57(4):847-55. PubMed ID: 9314589
[TBL] [Abstract][Full Text] [Related]
25. Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781.
Zussman A; Lara L; Lara HH; Bentwich Z; Borkow G
AIDS; 2003 Mar; 17(5):653-61. PubMed ID: 12646787
[TBL] [Abstract][Full Text] [Related]
26. Human immunodeficiency virus in cervicovaginal secretions and perinatal transmission.
Maiques V; Garcia-Tejedor A; Perales A; Córdoba J
Int J Gynaecol Obstet; 2004 Mar; 84(3):249-51. PubMed ID: 15001374
[No Abstract] [Full Text] [Related]
27. PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide.
D'Cruz OJ; Samuel P; Uckun FM
Biol Reprod; 2004 Dec; 71(6):2037-47. PubMed ID: 15306558
[TBL] [Abstract][Full Text] [Related]
28. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
[TBL] [Abstract][Full Text] [Related]
29. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
[TBL] [Abstract][Full Text] [Related]
30. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides.
Van Herrewege Y; Michiels J; Waeytens A; De Boeck G; Salden E; Heyndrickx L; van den Mooter G; de Béthune MP; Andries K; Lewi P; Praet M; Vanham G
Antiviral Res; 2007 May; 74(2):111-24. PubMed ID: 17097156
[TBL] [Abstract][Full Text] [Related]
31. Coming of age: reconstruction of heterosexual HIV-1 transmission in human ex vivo organ culture systems.
Southern PJ; Horbul JE; Miller BR; Maher DM
Mucosal Immunol; 2011 Jul; 4(4):383-96. PubMed ID: 21430654
[TBL] [Abstract][Full Text] [Related]
32. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
[TBL] [Abstract][Full Text] [Related]
33. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
[TBL] [Abstract][Full Text] [Related]
34. Mouse model of cervicovaginal papillomavirus infection.
Çuburu N; Cerio RJ; Thompson CD; Day PM
Methods Mol Biol; 2015; 1249():365-79. PubMed ID: 25348320
[TBL] [Abstract][Full Text] [Related]
35. Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity.
Gali Y; Ariën KK; Praet M; Van den Bergh R; Temmerman M; Delezay O; Vanham G
J Virol Methods; 2010 May; 165(2):186-97. PubMed ID: 20138087
[TBL] [Abstract][Full Text] [Related]
36. HIV type 1 cervicovaginal reservoirs in the era of HAART.
Nunnari G; Sullivan J; Xu Y; Nyirjesy P; Kulkosky J; Cavert W; Frank I; Pomerantz RJ
AIDS Res Hum Retroviruses; 2005 Aug; 21(8):714-8. PubMed ID: 16131311
[TBL] [Abstract][Full Text] [Related]
37. Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs.
Hijazi K; Cuppone AM; Smith K; Stincarelli MA; Ekeruche-Makinde J; De Falco G; Hold GL; Shattock R; Kelly CG; Pozzi G; Iannelli F
PLoS One; 2015; 10(6):e0131405. PubMed ID: 26102284
[TBL] [Abstract][Full Text] [Related]
38. Shedding of HIV-1 subtype E in semen and cervico-vaginal fluid.
Sutthent R; Chaisilwattana P; Roongpisuthipong A; Wirachsilp P; Samrangsarp K; Chaiyakul P; Puthavathana P; Wasi C
J Med Assoc Thai; 1997 Jun; 80(6):348-57. PubMed ID: 9240008
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
Cole AM; Cole AL
Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
[TBL] [Abstract][Full Text] [Related]
40. Role of semen in modulating the female genital tract microenvironment--implications for HIV transmission.
Doncel GF; Anderson S; Zalenskaya I
Am J Reprod Immunol; 2014 Jun; 71(6):564-74. PubMed ID: 24702729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
